Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2010; 56(6): 93-99


Interrelations of uric acid metabolismindices with insulinand testosteron levels in men withtype 2 diabetes

N.M.Gurina, O.V.Korpacheva-Zinych,A.A.Shuprovich.

    V.P. Komissarenko Institute of Endocrinology and Metabo-lism of Асademy of Medical Sciences, Kyiv


Abstract

95 men aged 45-65, suffering from type 2 diabetes for 0.1-20 years (4.5±1.4) were examined. Hypoandrogenia (serum testosteron < 10,4 nmol/ml) was noted in 37 % of investigated patients. Hyperuricemia (HUA), defined by serum uric acid (UAs) content more than 450 pmol/L, was detected in 34 % of subjects. In 74 % of patients there was a high level of 24h UA urine excretion (UAu>4.43 mmol), suggesting a hyperpro-duction of UA. Because the level of uricemia is defined by UA production and extretion, we outline two main types of alter­ations in UA methabolism: normouricemic, hyperuricosuric and hyperuricemic . In normouricemic and hyperuricosuric men UA excretion growth in parallel with the rate of kidney filtration, obesity, glicemia. High urate elimination index (UEI) suggests a decrease of UA reabsorbtion in kidney. The results allow us to suggest a significance of insulin and testosterone influence on regulation of UA metabolism in aged men with type 2 diabetes and insulin resistance syndrome.

References

  1. Балкаров И.М. Подагрическая (уратная) почка. - В кн: Диагностика и терапия в клинике внутренних болез-ней. - М.: Здоровье человека, 2004. - С.219-233.2. Гинзбург М.М., Козупица Г.С. Синдром инсулино-резистентности // Пробл. эндокринологии. - 1997. -43,№1. -С.40-43.
  2. Демидова Т.Ю., Аметов А.С., Титова И.О. Современные возможности коррекции инсулинорезис-тентности у пациентов с метаболическим синдромом // Терап. архив. - 2006. - 78, № 10. - С. 36-40.
  3. Дудинская В., Хлынчак А., Скотницкая Е., Суска М. Метаболизм пуринов в эритроцитах человека (обзор) //Биохимия. - 2006. - 71, №5. -С. 581-591.
  4. Кинев К.Г. Подагра. - М.: Медицина, 1980. - 124 с.
  5. Мадянов И.В., Балаболкин М.И., Марков Д.С., Маркова Т.Н. Основные причины гиперурикемии при сахарном диабете // Терап. архив. - 2000. - №2. - С.58-60.
  6. Мухин Н.А., Балкаров И.М., Бритов А.Н. Тубулоинтерстициальный нефрит и артериальная гипертония - клиническое и популяционное значение //Тамже. - 1997. - 69,№7. -С.5-10.
  7. Оранская А.Н., Мкртумян A.M. Болезнь без возраста, болезнь без времени // Здоровье Украины. -2008. - 1, №182. -С.36-37.
  8. 9. Руководство по клинической лабораторной диагностике / Под ред. В.В.Меньшикова. - М.: Медицина, 1982. - 576 с. 10.ШамхаловаМ.Ш.,КлефортоваИ.И., Трубицына Н.П., Шестакова М.В. Поражение почек при СД 2-го типа (обзор) // Терап. архив. - 2006 . - 78, №10. - С. 27-33.
  9. Шестакова М.В., Чугунова Л.А., Шамханова М.Ш. Диабетическая нефропатия: факторы риска быст-рого прогрессирования почечной недостаточности //Тамже. - 1999. -№6. -С.45-49.
  10. Byrne C., Wareham N., Day N. Decreased non-esteri-fied fatty acid suppression and features and of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance // Diabe-tologia. - 1995. -38, № 11. - P. 1358-1366.
  11. Dodesini A., Lepore G., Tiengo A. Insulin resistance as a progression promoter in diabetic nephropathy // Ibid. - 2004. - 47 (S.1), A21 (Ref. 50).
  12. Fox J., Kelley W. Human phosphoribosylpy-rophosphate syntetase // J.Biol. Chem. - 1972. - 247, №7. - P. 2126-2131.
  13. Gazziola C, Ferraro P., Moras M. Cytosolic high Km 5’(3’)-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism // J. Biol. Chem. -2001. - 276, №9. - P. 6185-6190.
  14. Geloneze S., Tambascia M., Parejra J. Non-esterified fatty acid (NEFA) release in vivo by visceral adipose tissue in humans // Diabetologia. - 2004. - 47, № 51, A 54, Ref. 139.
  15. Harman S.M., Metter E.J., Tobin J.D. Baltimore Longitudinal Study of Aging. Longitudinal effects of ag­ing on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging // J. Clin. Endocrinol. and Metabol. - 2001. - 86. - P. 724-731.
  16. Levinson D.J. Rat hepatic xanthine oxidase activity // Amer. J. Epidemiol. - 2008. - 23, № 1. - P. 77-82.
  17. 19. Ljubojevic M., Herak-Kramberger C.M., Hagos Y., Bahn A., Endou H., Burckhardt G., Sabolic I. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition // Amer. J. Physiol. Renal Physiol. 2004. -287. -P. F124-F138.
  18. 20. Matsumoto S., Koshiishi I., Inoguchi T. Confirmation of superoxide generation via xantine oxidase in streptozotocin-induced diabetic mice // Free Radic. Res. -2003. - 37,№7. - P.767-772. 21.
  19. Matthews D., Hosker J., Rudenski A., Naylor B., Nreacer D., Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man // Diabetologia. - 1985. - 28. - P. 412-419.
  20. Nakagawa T., Tuttle K., Short R. Johnson R. J. Hy­pothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome // Nat. Clin. Pract. Nephrol. - 2005. - № 1. - P. 80-86.
  21. Orwoll E., Lambert L.C., Marshall L.M. Testosterone and estradiol among older men // J. Clin. Endocrinol. and Metabol. - 2006. - 91, №4. - P. 1336-1344.
  22. Pizzichini M., Leoncini R., Vannoni D., Marinello E., Pagani R. The influence of testosterone on purine nucleotide metabolism in rat liver // Life Sci. - 1995. -57. - P. 2127-2135.
  23. Reaven G. The kidney: An anwilling accomplice in syndrome X // Amer. J. Kidney Dis. - 1997. - 30, № 6. -P. 928-931.
  24. Sala-Newby G.B., Freeman N.V., Skladanowski A.C. Distinct roles for recombinant cytosolic 5’-nucleoti­dase-I and -II in AMP catabolism in COS-7 and H9c2 rat myoblast cell lines // J. Biol. Chem. - 2000. - 275, №16. - P. 11666-11671.
  25. Sekine T., Miyazaki H., Endou H. Molecular physiology of renal organic anion transporters // Amer. J. Physiol. Renal Physiol. - 2006. - 290. - P. F251-F261.
  26. Taniguchi Y, Hayashi T., Tsumura K., Endo G., Fujii S., Okada K. Serum uric acid and risk for hypertension and type 2 diabetes in Japanese men: The Osaca Helth Sur­vey // J. Hypertens. - 2001. - 19, № 7. - P.1209-1215.
  27. 29. Vizzotto L., Vartemati M., Marinello E., Leoncini R. Pagani R., Pizzichini M. Effect of testosterone on purine metabolism and morphometric parameters in the rat liver // Mol. Cell. Endocrinol. - 1996. - 119. - P. 123-127.
  28. 30. Xiang G., Qi Lu, Qiao N. Intake of added sugar and sugar-sweetened drink and serum uric acid concent­ration in us men and women // Hypertension. - 2007. -50. - P. 306.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.